Not so fast: the reformulation of fentanyl and breakthrough chronic non-cancer pain.
Markman
John D
JD
Director, Neuromedicine Pain Management Center and Translational Pain Research, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 670 Rochester, NY 14642, USA.
D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use*; D002908:Chronic Disease; D017277:Drug Approval; D005283:Fentanyl / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009293:Opioid-Related Disorders / Q000209:etiology* / Q000517:prevention & control; D010146:Pain / Q000188:drug therapy* / Q000517:prevention & control*; D018570:Risk Assessment; D014481:United States
D000701:Analgesics, Opioid; D005283:Fentanyl